Company profile

Cullinan Therapeutics, Inc. insider acquisitions

Company CIK 0001789972 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
CGEM · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 21, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 2 of 2 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 28, 2025Cullinan Therapeutics, Inc.Common stock, $0.0001 par value per shareNichols Weston · Lynx1 Capital Management LPPurchase
Oct 17, 2025Cullinan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Oct 16, 2025Cullinan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Oct 15, 2025Cullinan Therapeutics, Inc.Common StockNichols Weston · Lynx1 Capital Management LPPurchase
Oct 14, 2025Cullinan Therapeutics, Inc.Common stock, $0.0001 par value per share ("Common Stock")Nichols Weston · Lynx1 Capital Management LPPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

CGEM · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Joint filing · amounts unallocatedPurchaseCommon stock, $0.0001 par value per shareNon-derivative security · Code P165,6678.4005 *Value: 1,391,685.6335Currency not specifiedView ↗
Trade: Joint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P32,2177.8395 *Value: 252,565.1715Currency not specifiedView ↗
Trade: Joint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P150,0008.855 *Value: 1,328,250Currency not specifiedView ↗
Trade: Joint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P51,5007.9427 *Value: 409,049.05Currency not specifiedView ↗
Trade: Joint filing · amounts unallocatedPurchaseCommon stock, $0.0001 par value per share ("Common Stock")Non-derivative security · Code P15,0327.587 *Value: 114,047.784Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →